# Bivalirudin

NDC: 42023-622
Generic name: Bivalirudin
Labeler / Manufacturer: Endo USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20230619

FDA application: NDA211215

## Active ingredients

- BIVALIRUDIN: 250 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"42023-622"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=42023-622
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=91cf9d00-29e0-4357-a184-f70026c47edb